HTWR 74.26 Heartware International $HTWR Hit a 52
Post# of 24
Posted On: 11/19/2014 11:25:34 AM
HTWR 74.26 Heartware International $HTWR Hit a 52 week low of 74.26 Closing the day 10:44 at 74.26 -1.92 -2.52% With a day low of 74.26 and a total volume of 45,217.
HTWR Recent Posts: http://investorshangout.com/HeartWare-Interna...TWR-54388/
HTWR Heartware International Recent Headline News
HeartWare Presentation At The Canaccord Genuity 2014 Medical Technology & Diagnostics Forum To Be Webcast
PR Newswire - Thu Nov 13, 11:11AM CST
HeartWare International, Inc. (NASDAQ:HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug Godshall is scheduled to present at the Canaccord Genuity 2014 Medical Technology & Diagnostics Forum at 10:00 a.m. EST on Thursday, November 20, 2014. The one-day conference is being held at the Westin Grand Central, New York.
HTWR: 74.15 (-2.03)
Update: Heartware International Q3 2014 Earnings
Andy Batts - at Seeking Alpha - Sat Nov 08, 1:38PM CST
HTWR: 74.15 (-2.03)
HeartWare Presentation At The Credit Suisse 2014 Healthcare Conference To Be Webcast
PR Newswire - Fri Nov 07, 8:00AM CST
HeartWare International, Inc. (NASDAQ:HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug Godshall is scheduled to present at the Credit Suisse 2014 Healthcare Conference at 2:00 p.m. MST (4:00 pm EST) on Wednesday, November 12, 2014. The conference is being held November 10-13 at the Arizona Biltmore in Phoenix.
HTWR: 74.15 (-2.03)
Heartware International (HTWR) Downgraded From Hold to Sell
at The Street - Mon Nov 03, 8:38AM CST
Heartware International (HTWR) has been downgraded by TheStreet Ratings from Hold to Sell with a ratings score of D+.
HTWR: 74.15 (-2.03)
HeartWare International ups revenues by 25% in Q3
Seeking Alpha - at Seeking Alpha - Fri Oct 31, 12:26PM CDT
HTWR: 74.15 (-2.03)
Is Haemonetics (HAE) Poised to Beat on Q2 Earnings? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 30, 5:15PM CDT
Haemonetics (HAE) has delivered positive earnings surprises in three of the past four quarters with an average beat of 1.9%
HAE: 36.58 (-1.02), HTWR: 74.15 (-2.03), HOLX: 26.55 (-0.09), HSP: 59.00 (-0.72)
Nasdaq stocks posting largest percentage decreases
AP - Thu Oct 30, 5:02PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
BBOX: 21.52 (-1.02), AFOP: 12.66 (-0.22), AMCC: 5.81 (-0.26), NSIT: 23.46 (-0.62), ARAY: 7.23 (-0.14), HTWR: 74.15 (-2.03), CCUR: 6.86 (-0.03), THRM: 39.57 (-0.95), RPXC: 13.07 (-0.39), BWEN: 6.99 (-0.20), PRXL: 55.42 (-0.47), AZPN: 36.82 (-1.06), BBSI: 22.35 (-0.73), CRUS: 17.89 (-0.41), ARCP: 8.71 (-0.11), PCRX: 90.07 (-0.67), XOOM: 14.38 (-0.55)
Heartware International's (HTWR) CEO Douglas Godshall on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Oct 30, 2:51PM CDT
HTWR: 74.15 (-2.03)
Heartware International (HTWR) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Oct 30, 6:55AM CDT
HTWR: 74.15 (-2.03)
Heartware beats by $0.01, misses on revenue
Seeking Alpha - at Seeking Alpha - Thu Oct 30, 6:40AM CDT
HTWR: 74.15 (-2.03)
HeartWare International Reports $68.6 Million In Third Quarter 2014 Revenue; 25% Increase From Third Quarter 2013
PR Newswire - Thu Oct 30, 5:58AM CDT
HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced revenue of $68.6 million for the third quarter ended September 30, 2014, a 25% increase compared to $54.8 million in revenue for the same period of 2013.
HTWR: 74.15 (-2.03)
Can Qiagen (QGEN) Surprise Earnings Estimates in Q3? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Oct 28, 5:17PM CDT
In Japan, Qiagen (QGEN) performed impressively in the first half of 2014 on a year-over-year basis.
QGEN: 23.75 (-0.22), HTWR: 74.15 (-2.03), HOLX: 26.55 (-0.09), HSP: 59.01 (-0.71)
Will Cardinal Health (CAH) Disappoint Earnings in Q1? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Oct 28, 5:10PM CDT
Our proven model does not conclusively show that Cardinal Health Inc. (CAH) is likely to beat earnings this quarter.
DSCI: 8.37 (-0.16), CAH: 80.06 (-0.95), HTWR: 74.15 (-2.03), HSIC: 132.03 (-0.36)
Will PerkinElmer (PKI) Disappoint This Earnings Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Oct 28, 4:59PM CDT
PerkinElmer (PKI) has managed to perform decently across several product lines and also posted solid operating results in the previous quarter.
HTWR: 74.15 (-2.03), CRL: 63.56 (-0.38), HSIC: 132.03 (-0.36), PKI: 43.58 (-0.28)
Can Ecolab Inc. (ECL) Surprise This Earnings Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Oct 27, 2:58PM CDT
Our proven model does not conclusively show that Ecolab Inc. (ECL) is likely to beat earnings this quarter.
HTWR: 74.15 (-2.03), HOLX: 26.55 (-0.09), HSP: 59.01 (-0.71), ECL: 112.98 (-0.20)
Is LabCorp (LH) Likely to Disappoint Earnings in Q3? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Oct 27, 2:20PM CDT
Laboratory Corp. of America Holdings (LH) is scheduled to release its third-quarter 2014 results before the opening bell on Oct 28.
LH: 101.27 (+0.09), HTWR: 74.15 (-2.03), HOLX: 26.55 (-0.09), HSP: 59.01 (-0.71)
Will DENTSPLY (XRAY) Disappoint Earnings this Season?
HTWR Recent Posts: http://investorshangout.com/HeartWare-Interna...TWR-54388/
HTWR Heartware International Recent Headline News
HeartWare Presentation At The Canaccord Genuity 2014 Medical Technology & Diagnostics Forum To Be Webcast
PR Newswire - Thu Nov 13, 11:11AM CST
HeartWare International, Inc. (NASDAQ:HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug Godshall is scheduled to present at the Canaccord Genuity 2014 Medical Technology & Diagnostics Forum at 10:00 a.m. EST on Thursday, November 20, 2014. The one-day conference is being held at the Westin Grand Central, New York.
HTWR: 74.15 (-2.03)
Update: Heartware International Q3 2014 Earnings
Andy Batts - at Seeking Alpha - Sat Nov 08, 1:38PM CST
HTWR: 74.15 (-2.03)
HeartWare Presentation At The Credit Suisse 2014 Healthcare Conference To Be Webcast
PR Newswire - Fri Nov 07, 8:00AM CST
HeartWare International, Inc. (NASDAQ:HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug Godshall is scheduled to present at the Credit Suisse 2014 Healthcare Conference at 2:00 p.m. MST (4:00 pm EST) on Wednesday, November 12, 2014. The conference is being held November 10-13 at the Arizona Biltmore in Phoenix.
HTWR: 74.15 (-2.03)
Heartware International (HTWR) Downgraded From Hold to Sell
at The Street - Mon Nov 03, 8:38AM CST
Heartware International (HTWR) has been downgraded by TheStreet Ratings from Hold to Sell with a ratings score of D+.
HTWR: 74.15 (-2.03)
HeartWare International ups revenues by 25% in Q3
Seeking Alpha - at Seeking Alpha - Fri Oct 31, 12:26PM CDT
HTWR: 74.15 (-2.03)
Is Haemonetics (HAE) Poised to Beat on Q2 Earnings? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 30, 5:15PM CDT
Haemonetics (HAE) has delivered positive earnings surprises in three of the past four quarters with an average beat of 1.9%
HAE: 36.58 (-1.02), HTWR: 74.15 (-2.03), HOLX: 26.55 (-0.09), HSP: 59.00 (-0.72)
Nasdaq stocks posting largest percentage decreases
AP - Thu Oct 30, 5:02PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
BBOX: 21.52 (-1.02), AFOP: 12.66 (-0.22), AMCC: 5.81 (-0.26), NSIT: 23.46 (-0.62), ARAY: 7.23 (-0.14), HTWR: 74.15 (-2.03), CCUR: 6.86 (-0.03), THRM: 39.57 (-0.95), RPXC: 13.07 (-0.39), BWEN: 6.99 (-0.20), PRXL: 55.42 (-0.47), AZPN: 36.82 (-1.06), BBSI: 22.35 (-0.73), CRUS: 17.89 (-0.41), ARCP: 8.71 (-0.11), PCRX: 90.07 (-0.67), XOOM: 14.38 (-0.55)
Heartware International's (HTWR) CEO Douglas Godshall on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Oct 30, 2:51PM CDT
HTWR: 74.15 (-2.03)
Heartware International (HTWR) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Oct 30, 6:55AM CDT
HTWR: 74.15 (-2.03)
Heartware beats by $0.01, misses on revenue
Seeking Alpha - at Seeking Alpha - Thu Oct 30, 6:40AM CDT
HTWR: 74.15 (-2.03)
HeartWare International Reports $68.6 Million In Third Quarter 2014 Revenue; 25% Increase From Third Quarter 2013
PR Newswire - Thu Oct 30, 5:58AM CDT
HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced revenue of $68.6 million for the third quarter ended September 30, 2014, a 25% increase compared to $54.8 million in revenue for the same period of 2013.
HTWR: 74.15 (-2.03)
Can Qiagen (QGEN) Surprise Earnings Estimates in Q3? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Oct 28, 5:17PM CDT
In Japan, Qiagen (QGEN) performed impressively in the first half of 2014 on a year-over-year basis.
QGEN: 23.75 (-0.22), HTWR: 74.15 (-2.03), HOLX: 26.55 (-0.09), HSP: 59.01 (-0.71)
Will Cardinal Health (CAH) Disappoint Earnings in Q1? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Oct 28, 5:10PM CDT
Our proven model does not conclusively show that Cardinal Health Inc. (CAH) is likely to beat earnings this quarter.
DSCI: 8.37 (-0.16), CAH: 80.06 (-0.95), HTWR: 74.15 (-2.03), HSIC: 132.03 (-0.36)
Will PerkinElmer (PKI) Disappoint This Earnings Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Oct 28, 4:59PM CDT
PerkinElmer (PKI) has managed to perform decently across several product lines and also posted solid operating results in the previous quarter.
HTWR: 74.15 (-2.03), CRL: 63.56 (-0.38), HSIC: 132.03 (-0.36), PKI: 43.58 (-0.28)
Can Ecolab Inc. (ECL) Surprise This Earnings Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Oct 27, 2:58PM CDT
Our proven model does not conclusively show that Ecolab Inc. (ECL) is likely to beat earnings this quarter.
HTWR: 74.15 (-2.03), HOLX: 26.55 (-0.09), HSP: 59.01 (-0.71), ECL: 112.98 (-0.20)
Is LabCorp (LH) Likely to Disappoint Earnings in Q3? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Oct 27, 2:20PM CDT
Laboratory Corp. of America Holdings (LH) is scheduled to release its third-quarter 2014 results before the opening bell on Oct 28.
LH: 101.27 (+0.09), HTWR: 74.15 (-2.03), HOLX: 26.55 (-0.09), HSP: 59.01 (-0.71)
Will DENTSPLY (XRAY) Disappoint Earnings this Season?
(0)
(0)HeartWare International (HTWR) Stock Research Links
Scroll down for more posts ▼